“Rise in Targeted Therapies and Innovative Drug Delivery Systems for Animal Skin Disorders”
- A key trend in the veterinary dermatology drugs market is the growing development of targeted therapies and advanced drug delivery systems designed to enhance treatment efficacy and reduce side effects
- These innovations include monoclonal antibodies and sustained-release formulations, which provide longer-lasting relief and reduce the need for frequent dosing
- For instance, treatments such as lokivetmab (a monoclonal antibody targeting canine atopic dermatitis) offer targeted action against specific allergens, improving symptom control with minimal systemic impact
- These advancements are improving treatment compliance, enhancing quality of life for animals, and expanding the therapeutic options available to veterinarians, thereby fueling market growth
